StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) stock

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.55−0.09 (-5.49%)

Close on Nov 18, 2026Market cap $11.15MP/E 1.1Yield –

Chemomab Therapeutics cash

Cash and short-term investments held at the end of each period.

Chemomab Therapeutics's cash was $6.70M at Jun 30, 2026. For fiscal 2025 it was $10.40M, down 27.3% from the year before. Over ten years it grew 16.8% a year on average. The highest annual figure on record is $15.24M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.40M-27.3%
FY2024Dec 31, 2024$14.30M+52.6%
FY2023Dec 31, 2023$9.37M-31.1%
FY2022Dec 31, 2022$13.60M-10.8%
FY2021Dec 31, 2021$15.24M+30.0%
FY2020Dec 31, 2020$11.73M-4.5%
FY2019Dec 31, 2019$12.28M+60.8%
FY2018Dec 31, 2018$7.64M+425.2%
FY2017Dec 31, 2017$1.45M-68.1%
FY2016Dec 31, 2016$4.56M+107.2%
FY2015Dec 31, 2015$2.20M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.70M+31.1%
Q4 FY2025Dec 31, 2025$10.40M+11.0%
Q2 FY2025Jun 30, 2025$9.50M-9.1%
Q4 FY2024Dec 31, 2024$14.30M-31.1%
Q2 FY2024Jun 30, 2024$5.11M-62.4%
Q4 FY2023Dec 31, 2023$9.37M-12.8%
Q2 FY2023Jun 30, 2023$10.46M+5.0%
Q1 FY2023Mar 31, 2023$20.77M+49.3%
Q4 FY2022Dec 31, 2022$13.60M-10.8%
Q3 FY2022Sep 30, 2022$10.74M-71.6%
Q2 FY2022Jun 30, 2022$9.96M-78.1%
Q1 FY2022Mar 31, 2022$13.91M-76.1%
Q4 FY2021Dec 31, 2021$15.24M+30.0%
Q3 FY2021Sep 30, 2021$37.80M+197.0%
Q2 FY2021Jun 30, 2021$45.45M+247.4%
Q1 FY2021Mar 31, 2021$58.23M+437.4%
Q4 FY2020Dec 31, 2020$11.73M-4.5%
Q3 FY2020Sep 30, 2020$12.73M-45.2%
Q2 FY2020Jun 30, 2020$13.08M-51.6%
Q1 FY2020Mar 31, 2020$10.84M-66.3%
Q4 FY2019Dec 31, 2019$12.28M+60.8%
Q3 FY2019Sep 30, 2019$23.24M+1498.4%
Q2 FY2019Jun 30, 2019$27.00M+491.7%
Q1 FY2019Mar 31, 2019$32.13M+1358.6%
Q4 FY2018Dec 31, 2018$7.64M–
Q4 FY2017Dec 31, 2017$1.45M–
Q4 FY2016Dec 31, 2016$4.56M–
Q4 FY2015Dec 31, 2015$2.20M–

More Chemomab Therapeutics figures

See a number that looks wrong?